Advances in Clinical Chemistry

Volume forty-four of the Advances in Clinical Chemistry series contains review articles of wide interest to clinical laboratory scientists and diagnostic adventurers. Articles in this volume cover such topics as Caspases in Myocardial Infarction; Deamidated Gliadin Peptides as Targets for Celiac Disease Specific Antibodies; Urokinase Receptor Variants in Tissue and Body Fluids; Proteomics in Cancer; Paraneoplastic Neurological Syndromes and Oncnerual Antibodies: Clinical and Immunological Aspects; Pathophysiologic Mechanisms of Angiogenesis; Bikunin (Urinary Trypsin Inhibitor): Structure, Biological Relevance and Measurement; and Gene Expression Assays.

Caspases in Myocardial Infarction.
Deamidated Gliadin Peptides as Targets for Celiac Disease Specific Antibodies.
Urokinase Receptor Variants in Tissue and Body Fluids.
Proteomics in Cancer.
Paraneoplastic Neurological Syndromes and Oncnerual Antibodies: Clinical and Immunological Aspects.
Pathophysiologic Mechanisms of Angiogenesis.
Bikunin (Urinary Trypsin Inhibitor): Structure, Biological Relevance and Measurement.
Gene Expression Assays.

Biochemists and clinical biochemists.

Dr Gregory S Makowski is a board certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in his joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President and Chief Scientific Officer for Clinical Laboratory Partners in Newington CT, USA.